Exam 3 Video Quiz Q & A and M12 CS Flashcards
(30 cards)
Goal INR is between 2.0 and 3.0.
-
Fish oils increase the risk of bleeding additively with warfarin.
-
With an INR of 3.2 it’s close to range, so just hold that dose of warfarin, continue with current 5 mg of warfarin, and re-check INR in one week. If it’s high again next week, reduce his TWD by 5-10% which would be 1.75 to 3.75.
-
If patient’s INR came back >10/unreadable, what would you order for him?
- Hold warfarin and administer vitamin K
-
If the patient has ASCVD and/or a a LDLc >190 mg/dL, target LDL reduction is >50%, and use a high intensity statin.
Also if their ASCVD risk is > 7.5%.
-
Pt to receive a high intensity statin if ASCVD risk is > 7.5%.
-
If there’s no LDL baseline on a patient, get their LDL down below 70.
-
HDL > 40 is desirable.
-
TG < 150 is desirable.
-
Once your TGs get up to over 500, you run the risk of developing pancreatitis.
-
Asthma: LAMA only.
For COPD, can use both SAMA and LAMA.
-
If you have a COPD patient in the hospital for a COPD exacerbation, you would put them on oral or injectible corticosteroids, and a LAMA combined with a LABA.
Once stable, and no sx of an exacerbation, and had a hx of asthma or eosinophils >300, or in a super-sever stage, then we would add it back (ICS).
-
ICS are only for stable COPD patients (those pts not experiencing an exacerbation).
-
GOLD 2020 GUIDELINES:
- Factors to assess when considering ICS:
Strong support:
- Hospitalization for COPD exacerbation
- ≥ 2 moderate COPD exacerbations/year
- Eosinophils >300
- History/concomitant asthma
-
Are IL-5 antibodies considered a last resort for asthma treatment?
Yes or No?
Yes.
Do all pts with SIHD receive the ASA + ACEI + Statin combo (unless allergic or CI)?
Answer:
Figure 7.5 is correct. But it also goes on to say if LV dysfunction, CKD, or MI they also get an ACEI/ARB. Remember the ABCDEs of IHD. Honestly though, 99% of people with IHD already have one of those comorbidities, the other 1% are variant angina, so that is why they say all patients with IHD need the combo.
-
In the objectives for HTN it is asked: “What are 2 drugs other than potyassium supplements that reduce potassium loss during diuresis?”
Directly the K-sparing diuretics amiloride and triamterene would count. Also spironolactone and the ACEI/ARB can cause hyperkalemia so they can definitely reduce potassium loss during diuresis too.
-
Cardioselective BBs: Are they OK to give to someone with asthma vs nonselective BB?
Answer: Yes, they are OK. I would just alert the patient that if they experience worsening asthma symptoms we would need to change their BB or choose a different medication. You can further break up the cardioselective BBs into ISA and non-ISA activity to be even more patient selective. Even though that does not matter for this exam.
-
Why is LTRA considered steroid-sparing?
It has everything to do with inflammation. By inhibiting certain leukotrienes this decreases inflammation in the lungs which decreases the need for topical anti-inflammatories like inhaled steroids.
-
Should we know the 1st gen antihistamines vs 2nd gen?
I would know which are which because 1st gen are for allergy exacerbation, and are not recommended for allergy prophylaxis due to severe side effects, while 2nd gen are the opposite.
-
Anything that ends in “-amine” is a 1st-gen antihistamine.
“-zines” and “-dines” are second generation.
-
For asthma, you would never use anything but a combo-inhaler (ICS/formoterol).
You would never give a LABA by itself for asthma.
-
LABAs can be given by themselves in COPD, but NOT in asthma.
LABAs: ending in “-terol.”
Formoterol, salmeterol, arfomoterol
-
EPR3 has step 6, and GINA only goes up to step 5.
-